VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+25.81%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$241M
AUM Growth
+$50.3M
(+26%)
Cap. Flow
+$11.6M
Cap. Flow
% of AUM
4.82%
Top 10 Holdings %
Top 10 Hldgs %
9.37%
Holding
372
New
47
Increased
146
Reduced
160
Closed
17
Top Buys
| 1 |
Brookfield Renewable
BEPC
|
$1.83M |
| 2 |
Western Midstream Partners
WES
|
$1.11M |
| 3 |
Delek US
DK
|
$829K |
| 4 |
Viper Energy
VNOM
|
$789K |
| 5 |
Oneok
OKE
|
$751K |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$1.61M |
| 2 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$1.13M |
| 3 |
AIV
Aimco
AIV
|
$1.11M |
| 4 |
Telefônica Brasil
VIV
|
$1.01M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$988K |
Sector Composition
| 1 | Healthcare | 29.53% |
| 2 | Real Estate | 18.96% |
| 3 | Energy | 16.61% |
| 4 | Materials | 11.31% |
| 5 | Utilities | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Realty Income
O
$53.5B
| $1.43M | 0.59% |
23,681
+2,734
| +13% | +$165K |
|
77
STAG Industrial
STAG
$6.86B
| $1.4M | 0.58% |
44,788
+2,209
| +5% | +$69.2K |
|
78
Ingredion
INGR
$8.23B
| $1.4M | 0.58% |
17,802
+3,131
| +21% | +$246K |
|
|
PTR
79
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $1.37M | 0.57% |
44,568
+8,938
| +25% | +$275K |
|
80
Telecom Argentina
TEO
$3.54B
| $1.35M | 0.56% |
206,391
+65,526
| +47% | +$430K |
|
|
GMRE
81
Global Medical REIT
GMRE
$503M
| $1.35M | 0.56% |
103,567
-4,427
| -4% | -$57.8K |
|
82
Dominion Energy
D
$50.6B
| $1.35M | 0.56% |
17,955
+2,953
| +20% | +$222K |
|
83
Cogent Communications
CCOI
$1.8B
| $1.35M | 0.56% |
22,482
+6,929
| +45% | +$415K |
|
84
Newmont
NEM
$81.8B
| $1.31M | 0.54% |
21,921
+521
| +2% | +$31.2K |
|
|
CEO
85
DELISTED
CNOOC Limited
CEO
| $1.24M | 0.51% |
13,518
+2,709
| +25% | +$248K |
|
86
TC Energy
TRP
$54.2B
| $1.23M | 0.51% |
30,196
+1,957
| +7% | +$79.7K |
|
|
OXLC
87
Oxford Lane Capital
OXLC
$1.77B
| $1.11M | 0.46% |
205,454
-27,902
| -12% | -$151K |
|
|
ECC
88
Eagle Point Credit Co
ECC
$960M
| $998K | 0.41% |
98,910
-22,927
| -19% | -$231K |
|
89
Agios Pharmaceuticals
AGIO
$1.97B
| $772K | 0.32% |
17,822
+5,424
| +44% | +$235K |
|
|
ITCI
90
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $766K | 0.32% |
24,085
+8,782
| +57% | +$279K |
|
|
SAGE
91
DELISTED
Sage Therapeutics
SAGE
| $745K | 0.31% |
8,611
-7,531
| -47% | -$652K |
|
92
Barings BDC
BBDC
$981M
| $740K | 0.31% |
80,465
+8,934
| +12% | +$82.2K |
|
|
RDUS
93
DELISTED
Radius Health, Inc.
RDUS
| $739K | 0.31% |
41,375
-3,106
| -7% | -$55.5K |
|
94
Ionis Pharmaceuticals
IONS
$9.64B
| $719K | 0.3% |
12,725
+2,712
| +27% | +$153K |
|
|
ONC
95
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.3B
| $690K | 0.29% |
2,669
-896
| -25% | -$232K |
|
96
United Therapeutics
UTHR
$17.2B
| $645K | 0.27% |
4,252
-812
| -16% | -$123K |
|
97
BioMarin Pharmaceuticals
BMRN
$11.2B
| $644K | 0.27% |
7,346
+1,817
| +33% | +$159K |
|
|
PNNT
98
Pennant Park Investment Corp
PNNT
$471M
| $635K | 0.26% |
137,760
+72,092
| +110% | +$332K |
|
99
Vertex Pharmaceuticals
VRTX
$102B
| $631K | 0.26% |
2,668
+492
| +23% | +$116K |
|
100
Acadia Pharmaceuticals
ACAD
$4.29B
| $624K | 0.26% |
11,675
-1,073
| -8% | -$57.3K |
|